logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Patently Innovative How Pharmaceutical Firms Use Emerging Patent Law To Extend Monopolies On Blockbuster Drugs Ron A Bouchard

  • SKU: BELL-4146952
Patently Innovative How Pharmaceutical Firms Use Emerging Patent Law To Extend Monopolies On Blockbuster Drugs Ron A Bouchard
$ 31.00 $ 45.00 (-31%)

4.8

84 reviews

Patently Innovative How Pharmaceutical Firms Use Emerging Patent Law To Extend Monopolies On Blockbuster Drugs Ron A Bouchard instant download after payment.

Publisher: Woodhead Publishing
File Extension: PDF
File size: 4.53 MB
Pages: 296
Author: Ron A. Bouchard
ISBN: 9781907568121, 9781908818089, 1907568123, 1908818085
Language: English
Year: 2012

Product desciption

Patently Innovative How Pharmaceutical Firms Use Emerging Patent Law To Extend Monopolies On Blockbuster Drugs Ron A Bouchard by Ron A. Bouchard 9781907568121, 9781908818089, 1907568123, 1908818085 instant download after payment.

Drug approval, drug patenting, pharmaceutical linkage, and public health policy; Empirical analysis of drug approval; Empirical analysis of pharmaceutical innovation and drug approval-drug patenting linkage; Empirical analysis of drug patenting in multiple high-value cohorts; Implications of empirical data: Are pharmaceutical linkage regulations a success? Future directions: Testable hypotheses and evolution toward global pharmaceutical linkage

Related Products